Wednesday, January 4, 2017

BRIEF-BioPharmX completes enrollment of Phase 2B OPAL trial for acne vulgaris

* BioPharmX completes enrollment of BPX-01 Phase 2B OPAL

clinical trial for acne vulgaris

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)